Serum Institute of India seeks emergency use authorisation...

New Delhi [India], December 7 (ANI): The Serum Institute of India (SII) has applied to the Drugs Controller...

Pfizer becomes first pharma company in India to seek...

New Delhi [India], December 6 (ANI): Pfizer India has become the first pharmaceutical firm to approach the Drugs...

DCGI gives nod for phase 3 trial of Bharat Biotech's COVID-19...

New Delhi [India], October 23 (ANI): In a major development, Drugs Controller General of India (DCGI) on Friday gave...

ICMR issues advisory on CRISPR technology-based SARS CoV-2 test

New Delhi [India], October 23 (ANI): The Indian Council of Medical Research (ICMR) on Thursday issued an advisory on...

Expert panel recommends DCGI to permit Dr Reddy's Lab to...

New Delhi [India], October 17 (ANI): The expert committee of Drugs Controller General of India (DCGI) on Friday...

Dr Reddy's Lab submits revised protocol to DCGI to conduct...

New Delhi [India], October 13 (ANI): Indian drug maker Dr Reddy's Laboratories (DRL) has submitted a revised...

DCGI directs Dr Reddy's lab to furnish fresh protocol to seek...

New Delhi [India], October 6 (ANI): In the latest development, the Drugs Controller General of India (DCGI) expert...

Dr Reddy's Laboratories seeks DCGI permission to conduct...

New Delhi [India], October 2 (ANI): Indian pharma giant Dr Reddy's Laboratories (DRL) has submitted an...

DCGI issues guidelines for pharma giants manufacturing...

New Delhi [India], September 23 (ANI): The Drugs Controller General of India (DCGI) has issued a new set of...

First cost, time-effective CRISPER test for Covid-19 gets nod...

New Delhi [India], September 20 (ANI): The Drugs Controller General of India (DCGI) has given approval to the Tata...

Drugs control organisation issues guidelines for trial,...

New Delhi [India], September 18 (ANI): The Central Drugs Standard Control Organisation (CDSCO) said the requirements...

DCGI gives nod to Serum Institute to restart phase 2,3 trials...

New Delhi [India], September 16 (ANI): The Drugs Controller General of India (DCGI) has allowed Serum Institute of...